Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program
pharmaceutical investing Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results
QIMC Extends DDH-26-05 Drilling to Beyond 1,000 Metres and Launches In-Situ Hydrogen Characterization and Extraction Program at Bennett Hill as Seismic Further Corroborates Two Distinct Hydrogen Systems in Nova Scotia
CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
